Changes in sexual behavior among HIV-infected women after initiation of HAART

American Journal of Public Health

Volumn 94, Issue 7, 2004, Pages 1141-1146

  Wilson, Tracey E ^a   Gore, Mary Elizabeth ^b   Greenblatt, Ruth ^c   Cohen, Mardge ^d   Minkoff, Howard ^a   Silver, Sylvia ^e   Robison, Esther ^f   Levine, Alexandra ^g   Gange, Stephen J ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Jr Hospital of Cook County   (United States)

^e GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; DISEASE TRANSMISSION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; RISK; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS LOAD;

EID: 3042732192     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.94.7.1141     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention. Update: trends in AIDS incidence, deaths, and prevalence-United States, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:165-173.
2. Palella F, Delaney K, Moorman A, et al. Declining morbidity and mortality among patients with advanced HIV infection. N Engl J Med. 1998;338:853-860.
3. Dilley J, Woods W, McFarland W. Are advances in treatment changing views about high-risk sex? N Engl J Med. 1997;337:501-502.
4. Pomerantz R. Primary HIV-1 resistance: a new phase in the epidemic? JAMA. 1999;282:1177-1179.
5. Wainberg M, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279:2000-2002.
6. Barkan S, Melnick S, Preston-Martin S, et al. The Women's Interagency HIV Study. Epidemiology. 1998; 9:117-125.
7. Guidelines for the use of antiretroviral agents in HIV-Infected adults and adolescents. Washington, DC: US Dept of Health and Human Services and Henry J. Kaiser Family Foundation. MMWR Morb Mortal Wkly Rep. 1998;47(RR-5):43-82. Also available at: http://aidsinfo.nih.gov//guidelines/default_db2.asp?id=50. Accessed April 29, 2004.
8. Bozzette S, Hays R, Berry S, Kanouse D, Wu A. Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:253-265.
9. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
10. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA. 1993;269:729-730.
11. Ahdieh L, Gange S, Greenblatt R, et al. Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus. Am J Epidemiol. 2000;152:923-933.
12. Cook J, Cohen M, Grey D, et al. Penetration and predictors of use of highly active antiretroviral therapy in a cohort of HIV-seropositive women. Am J Public Health. 2002;92:82-87.
13. Diggle P, Liang K, Zeger S. Analysis of Longitudinal Data. New York, NY: Oxford University Press; 1994.
14. Wilson T, Massad S, Riester K, et al. The sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study (WIHS). AIDS. 1999;13:591-598.
15. Wilson T. The sexual and reproductive behavior of women with HIV. Clin Obstet Gynecol. 2001;44: 289-299.
16. Wilson T, Barrón Y, Cohen M, et al. Adherence with antiretroviral therapy and associations with sexual behavior among a national sample of women with HIV. Clin Infect Dis. 2002;34:529-534.
17. Wilson T, Minkoff H. Decreased condom consistency associated with beliefs regarding HIV therapy and disease transmission among women with HIV-infection. J Acquir Immune Defic Syndr Hum Retrovirol. 2001;27:289-291.
18. Velasco-Hernandez JX, Gershengom HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis. 2002;2:487-493.
19. Crepaz N, Marks G. Towards an understanding of sexual risk behavior in people living with HIV: a review of social psychological and medical findings. AIDS. 2002;16:135-149.